Nephros Inc. (NASDAQ:NEPH) Sees Significant Growth in Short Interest

Nephros Inc. (NASDAQ:NEPH) was the target of a large growth in short interest during the month of January. As of January 30th, there was short interest totaling 9,897 shares, a growth of 32.0% from the January 15th total of 7,496 shares. Approximately 0.1% of the company’s stock are sold short. Based on an average daily trading volume, of 44,093 shares, the days-to-cover ratio is presently 0.2 days. Based on an average daily trading volume, of 44,093 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.1% of the company’s stock are sold short.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Nephros in a research report on Thursday, January 22nd. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, Nephros currently has an average rating of “Moderate Buy” and a consensus price target of $6.00.

Nephros Price Performance

Shares of NEPH traded down $0.10 during mid-day trading on Tuesday, reaching $4.00. 81,085 shares of the company’s stock were exchanged, compared to its average volume of 49,316. The stock has a market capitalization of $42.52 million, a PE ratio of 30.77 and a beta of 1.40. The business’s fifty day simple moving average is $4.63 and its 200-day simple moving average is $4.64. Nephros has a 52-week low of $1.39 and a 52-week high of $6.42.

Institutional Investors Weigh In On Nephros

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Geode Capital Management LLC grew its holdings in shares of Nephros by 3.2% during the second quarter. Geode Capital Management LLC now owns 93,187 shares of the company’s stock worth $381,000 after buying an additional 2,898 shares during the last quarter. Renaissance Technologies LLC raised its stake in Nephros by 25.8% during the 4th quarter. Renaissance Technologies LLC now owns 103,772 shares of the company’s stock valued at $506,000 after acquiring an additional 21,272 shares during the last quarter. Topline Capital Management LLC lifted its position in Nephros by 24.9% during the 3rd quarter. Topline Capital Management LLC now owns 596,300 shares of the company’s stock worth $2,820,000 after acquiring an additional 118,851 shares during the period. Navellier & Associates Inc. purchased a new position in shares of Nephros in the 4th quarter valued at approximately $133,000. Finally, Mesirow Financial Investment Management Inc. increased its holdings in shares of Nephros by 262.3% in the fourth quarter. Mesirow Financial Investment Management Inc. now owns 50,000 shares of the company’s stock valued at $244,000 after purchasing an additional 36,200 shares during the period. 41.10% of the stock is owned by hedge funds and other institutional investors.

About Nephros

Nephros, Inc is a development-stage company specializing in advanced water filtration and purification technologies for medical, laboratory, industrial and defense applications. The company’s core offering centers on proprietary hollow fiber ultrafilters designed to remove bacteria, viruses, endotoxins and particulates from water streams. These ultrafilters are used in hemodialysis systems to protect patient treatment, in pharmaceutical and laboratory environments to ensure water quality and in critical field-deployable units for military and emergency response.

The company’s product portfolio includes standalone filtration cartridges for point-of-use and point-of-entry installations in dialysis clinics and hospitals, as well as bench-top and portable water purification systems.